Morrison Foerster, Ropes & Gray and Mori Hamada & Matsumoto have advised Bain Capital on its acquisition of Mitsubishi Tanabe Pharma Corporation in a JPY510 billion (USD3.3 billion) carve-out transaction from Mitsubishi Chemical Group.
Tokyo-based M&A/private equity partners Jeremy White and Randy Laxer co-led the Morrison Foerster team.
Ropes & Gray’s advisory team includes partners Tsuyoshi Imai, Ben Morris and Ruchit Patel, while Mori Hamada & Matsumoto partners Hajime Tanahashi, Rintaro Shinohara and Yusuke Takamiya led the firm’s team.
Bain Capital’s private equity and life sciences teams across Asia and North America spearheaded the investment.
Bain Capital is one of the world’s leading private investment firms with around USD185 billion in assets under management.
Mitsubishi Tanabe Pharma manufactures and sells pharmaceuticals, centred on ethical drugs.
